CB
Healthcare & Life Sciences
cCAM Biotherapeutics
cCAM Biotherapeutics is a Healthcare & Life Sciences startup, since acquired, 1 tracked investor.
Acquiredacquired
acquired
Stage
1
Investors
About cCAM Biotherapeutics
cCAM Biotherapeutics is a startup. cCAM Biotherapeutics has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
cCAM Biotherapeutics developed immunotherapies for cancer, including CM-24, an immunomodulatory antibody that blocks a novel immune checkpoint to enhance the immune system's ability to attack tumors. The company was acquired by Merck in July 2015.
Explore cCAM Biotherapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.